Minerva Neurosciences logo

Minerva Neurosciences

NERV | NASDAQ
Chart Builder DCF Calculator
$2.20
-$0.10 (-4.35%)
At close: Nov 16, 2026, 4:00 PM ET
$2.21
+$0.01 (+0.45%)
After-hours: Nov 16, 2026, 7:30 PM ET
-4.35%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 14, 2026
25.2
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #923/1021 (Top 90%)

Key Statistics

Market Data

Market Cap $109.64M
1D Range
2.18 2.30
52W Range
2.18 8.07

Valuation (TTM)

PE -0.08
PB -0.00
EV/EBITDA -0.08

Valuation (NTM)

Forward PE N/A
Forward PEG -0.00
Price Target $10.00
Loading financial charts...

Profile

Minerva Neurosciences, Inc. functions as a biopharmaceutical firm in the clinical development stage, primarily dedicated to uncovering and bringing to market novel therapeutic options for disorders af...

Sector Healthcare
Industry Biotechnology
Employees 7
IPO Date Jul 1, 2014
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
2
Consensus
Hold
Price Target
$10.00
Upside
+354.55%
Buy (1)
Hold (1)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.